Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression

Oncogene

Volumn 23, Issue 33, 2004, Pages 5675-5681

  Bandyopadhyay, Sucharita ^a   Pai, Sudha K ^a   Hirota, Shigeru ^b   Hosobe, Sadahiro ^b   Takano, Yukio ^b   Saito, Ken ^b   Piquemal, David ^c   Commes, Therese ^c   Watabe, Misako ^a   Gross, Steven C ^a   Wang, Ying ^a   Ran, Sophia ^a   Watabe, Kounosuke ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKITA RED CROSS HOSPITAL   (Japan)

^c Universite Montepillar II   (France)

Author keywords

Invasion; Marker; Metastasis; Methylation

Indexed keywords

AZACITIDINE; RNA; TUMOR SUPPRESSOR PROTEIN; DEVELOPMENTALLY REGULATED GTP BINDING PROTEIN; DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; DIFFERENTIATION RELATED GENE 1; DNA METHYLATION; DOWN REGULATION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA ISOLATION; TRANSLATION REGULATION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CELL CULTURE; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GENETICS; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GTP-BINDING PROTEINS; HUMANS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 3342962720     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207734     Document Type: Article

References (18)

1. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M and Watabe K. (2003). Cancer Res., 63, 1731-1736.
2. Davol PA, Bagdasaryan R, Elfenbein GJ, Maizel AL and Frackelton Jr AR. (2003). Cancer Res., 6, 6772-6783.
3. Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Jung B, Davidson NE and Sukumar S. (2001). Lancet, 57, 335-336.
4. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and Pardee AB. (2000). Cancer Res., 60, 749-755.
5. Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G and Steeg PS. (2001). Cancer Res., 61, 2320-2327.
6. Kim HL, Vander Griend DJ, Yang X, Benson DA, Dubauskas Z, Yoshida BA, Chekmareva MA, Ichikawa Y, Sokoloff MH, Zhan P, Karrison T, Lin A, Stadler WM, Ichikawa T, Rubin MA and Rinker-Schaeffer CW. (2001). Cancer Res., 61, 2833-2837.
7. Kokame K, Kato H and Miyata T. (1996). J. Biol. Chem., 271, 29659-29665.
8. Krueger JS, Keshamouni VG, Atanaskova N and Reddy KB. (2001). Oncogene, 20, 4209-4218.
9. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA and Lee SW. (1998). Cancer Res., 58, 4439-444.
10. Lin TM and Chang C. (1997). Proc. Natl. Acad. Sci. USA, 94, 4988-4993.
11. Masuda K, Ono M, Okamoto M, Morikawa W, Otsubo M, Migita T, Tsuneyoshi M, Okuda H, Shuin T, Naito S and Kuwano M. (2003). Int. J. Cancer., 105, 803-810.
12. Okuda T and Kondoh H. (1999). Biochem. Biophys. Res. Commun., 266, 208-215.
13. Park H, Adams MA, Lachat P, Bosman F, Pang SC and Graham CH. (2000). Biochem. Biophys. Res. Commun., 276, 321-328.
14. Ulrix W, Swinnen JV, Heyns W and Verhoeven G. (1999). FEBS Lett., 455, 23-26.
15. Unoki M and Nakamura Y. (2001). Oncogene, 20, 4457-4465.
16. van Beizen N, Dinjens WN, Diesveld MP, Groen NA., van der Made AC, Nozawa Y, Vlietstra R, Trapman J and Bosman FT. (1997). Lab. Invest., 77, 85-92.
17. Yamada SD, Hickson JA, Hrobowski Y, Vander Griend DJ, Benson D, Montag A, Karrison T, Huo D, Rutgers J, Adams S and Rinker-Schaeffer CW. (2002). Cancer Res., 62, 6717-6723.
18. Zhou D, Salnikow K and Costa M. (1998). Cancer Res., 58, 2182-2189.